{"id":5046,"date":"2025-10-30T08:40:43","date_gmt":"2025-10-30T08:40:43","guid":{"rendered":"https:\/\/regenerated.health\/ibs\/"},"modified":"2026-03-31T12:52:05","modified_gmt":"2026-03-31T12:52:05","slug":"ibs","status":"publish","type":"post","link":"https:\/\/regenerated.com\/blog\/ibs\/","title":{"rendered":"IBS (Irritable Bowel Syndrome): Types, Root Causes, and Effective Treatment"},"content":{"rendered":"<div style=\"background-color:#f0f7f4;border-radius:12px;padding:28px 32px;margin-bottom:32px;\">\n<h2 style=\"color:#2e7d32;margin-top:0;font-size:1.4em;\">IBS, At a Glance<\/h2>\n<ul style=\"font-size:1.08em;line-height:1.8;margin-bottom:0;\">\n<li><strong>What it is:<\/strong> A functional gastrointestinal disorder defined by the Rome IV criteria, recurrent abdominal pain associated with changes in bowel habits, without structural damage<\/li>\n<li><strong>Subtypes:<\/strong> IBS-D (diarrhea-predominant), IBS-C (constipation-predominant), IBS-M (mixed), IBS-U (unsubtyped)<\/li>\n<li><strong>Prevalence:<\/strong> Affects 10-15% of the global population; up to 45 million Americans<\/li>\n<li><strong>Key insight:<\/strong> Up to 78% of IBS patients test positive for SIBO, suggesting a treatable root cause rather than a lifelong label<\/li>\n<li><strong>Best-supported treatments:<\/strong> Low-FODMAP diet, rifaximin (IBS-D), gut-directed hypnotherapy, antispasmodics, peppermint oil, and root-cause SIBO treatment<\/li>\n<\/ul>\n<\/div>\n<hr style=\"border:none;border-top:2px solid #e0e0e0;margin:36px 0;\">\n<p>If you&#8217;ve been told you have IBS, you&#8217;ve probably also been told some version of: <em>&#8220;Learn to live with it.&#8221;<\/em> Maybe you were handed a pamphlet about fiber, prescribed an antispasmodic, and sent on your way. That experience, being dismissed after a diagnosis of exclusion, is frustratingly common.<\/p>\n<p>But here&#8217;s what most conventional gastroenterologists won&#8217;t tell you: <strong>IBS is not a final answer. It&#8217;s a starting point.<\/strong> The label describes a pattern of symptoms. It doesn&#8217;t explain <em>why<\/em> those symptoms exist. And when you dig into the why, the gut-brain axis dysfunction, the small intestinal bacterial overgrowth, the visceral hypersensitivity, the microbiome disruption, you often find things that are genuinely treatable.<\/p>\n<p>This guide is built on that principle. We&#8217;ll walk through what IBS actually is according to modern diagnostic criteria, explore the three core mechanisms driving it, unpack the SIBO connection that changes everything for many patients, and lay out every evidence-based treatment option, from dietary strategies to pharmaceutical interventions to therapies your gastroenterologist may never have mentioned.<\/p>\n<h2>What Exactly Is IBS? The Rome IV Definition<\/h2>\n<p>Irritable bowel syndrome is classified as a <strong>disorder of gut-brain interaction<\/strong> (DGBI), what used to be called a &#8220;functional gastrointestinal disorder.&#8221; That term &#8220;functional&#8221; historically meant &#8220;we can&#8217;t find anything structurally wrong,&#8221; which unfortunately led many clinicians to treat IBS as psychosomatic. Modern research has thoroughly dismantled that framing.<\/p>\n<p>The <strong>Rome IV criteria<\/strong>, the current diagnostic standard, define IBS as:<\/p>\n<ul>\n<li>Recurrent abdominal pain, on average, at least 1 day per week in the last 3 months<\/li>\n<li>Associated with two or more of the following: related to defecation, associated with a change in stool frequency, associated with a change in stool form (appearance)<\/li>\n<li>Symptoms must have started at least 6 months before diagnosis<\/li>\n<\/ul>\n<p>Notice what&#8217;s <em>not<\/em> in those criteria: any mention of testing for underlying causes. That&#8217;s the gap this guide aims to fill.<\/p>\n<h2>The Four IBS Subtypes<\/h2>\n<p>IBS isn&#8217;t a single condition, it&#8217;s a spectrum. Your subtype matters because it directly influences which treatments are most likely to help you.<\/p>\n<p><strong>IBS-D (Diarrhea-Predominant):<\/strong> More than 25% of bowel movements are loose or watery (Bristol Stool Scale 6-7), and fewer than 25% are hard or lumpy. This is the subtype most strongly associated with SIBO, particularly hydrogen-dominant SIBO. Urgency, cramping, and post-meal rushing to the bathroom are hallmarks. Rifaximin has FDA approval specifically for this subtype.<\/p>\n<p><strong>IBS-C (Constipation-Predominant):<\/strong> More than 25% of bowel movements are hard or lumpy (Bristol Stool Scale 1-2), and fewer than 25% are loose. Often associated with methane-dominant SIBO (now called intestinal methanogen overgrowth, or IMO), because methane gas directly slows intestinal transit. Bloating, straining, and a sensation of incomplete evacuation are common.<\/p>\n<p><strong>IBS-M (Mixed):<\/strong> Both hard\/lumpy and loose\/watery stools occur more than 25% of the time. Patients often describe unpredictable alternation between constipation and diarrhea, sometimes within the same day. This subtype can involve both hydrogen and methane gas production.<\/p>\n<p><strong>IBS-U (Unsubtyped):<\/strong> Meets IBS criteria but doesn&#8217;t fit neatly into any of the above categories. Less commonly discussed but clinically relevant.<\/p>\n<div style=\"background-color:#fff8e1;border-left:4px solid #ffcc02;border-radius:8px;padding:20px 24px;margin:28px 0;\">\n<p style=\"margin:0;font-size:1.05em;\"><strong>Why your subtype matters:<\/strong> The treatment that resolves IBS-D may worsen IBS-C, and vice versa. A patient with methane-dominant SIBO causing IBS-C needs a fundamentally different antimicrobial protocol than someone with hydrogen-dominant SIBO causing IBS-D. Subtyping isn&#8217;t academic, it&#8217;s the first step toward targeted treatment.<\/p>\n<\/div>\n<h2>Three Core Mechanisms Behind IBS<\/h2>\n<p>Research over the past two decades has identified three interconnected mechanisms that drive IBS symptoms. Most patients have some combination of all three, which is why effective treatment usually needs to address multiple pathways simultaneously.<\/p>\n<div style=\"display:flex;flex-wrap:wrap;gap:20px;margin:32px 0;\">\n<div style=\"flex:1;min-width:260px;background-color:#e8f5e9;border-radius:12px;padding:24px;\">\n<h3 style=\"color:#2e7d32;margin-top:0;\">Gut-Brain Axis Dysfunction<\/h3>\n<p>The gut and brain communicate bidirectionally through the vagus nerve, the enteric nervous system (your &#8220;second brain&#8221;), and a complex web of neurotransmitters, including serotonin, 95% of which is produced in the gut. In IBS, this communication system is dysregulated. Stress amplifies gut symptoms. Gut inflammation alters mood and cognition. The system becomes a self-reinforcing loop: anxiety triggers gut symptoms, which trigger more anxiety. This isn&#8217;t &#8220;it&#8217;s all in your head&#8221;, it&#8217;s a measurable dysfunction in a physical communication system.<\/p>\n<\/div>\n<div style=\"flex:1;min-width:260px;background-color:#e3f2fd;border-radius:12px;padding:24px;\">\n<h3 style=\"color:#1565c0;margin-top:0;\">Visceral Hypersensitivity<\/h3>\n<p>In many IBS patients, the nerves lining the gut are hypersensitive, they interpret normal signals (gas, distension, muscle contractions) as pain. This is called visceral hypersensitivity, and it&#8217;s been documented in approximately 33-90% of IBS patients depending on the study. It explains why two people can eat the same meal, produce the same amount of intestinal gas, and one feels fine while the other is doubled over in pain. The gas isn&#8217;t the problem, the amplified pain signaling is. Treatments targeting this mechanism (like gut-directed hypnotherapy and neuromodulators) can be transformative.<\/p>\n<\/div>\n<div style=\"flex:1;min-width:260px;background-color:#fce4ec;border-radius:12px;padding:24px;\">\n<h3 style=\"color:#c62828;margin-top:0;\">Microbiome Disruption<\/h3>\n<p>The gut microbiome in IBS patients consistently shows reduced diversity and altered composition compared to healthy controls. Key patterns include reduced Bifidobacteria and Lactobacillus species, increased Firmicutes-to-Bacteroidetes ratios, and, critically, bacterial overgrowth in the small intestine (SIBO). Post-infectious IBS, which develops after food poisoning or gastroenteritis, demonstrates this mechanism most clearly: a single infectious event can permanently alter the microbiome and gut motility through autoimmune damage to the migrating motor complex. Understanding this mechanism is what makes the SIBO-IBS connection so important.<\/p>\n<\/div>\n<\/div>\n<h2>The SIBO-IBS Connection: The Most Important Thing Your Gastroenterologist Isn&#8217;t Telling You<\/h2>\n<p>This is where the IBS conversation fundamentally shifts. <strong>Small intestinal bacterial overgrowth (SIBO)<\/strong>, a condition where bacteria that normally live in the large intestine proliferate in the small intestine, has been found in <strong>up to 78% of IBS patients<\/strong> in clinical studies. That&#8217;s not a minor overlap. That&#8217;s a potential root cause hiding in plain sight.<\/p>\n<p>The connection makes biological sense. When bacteria overgrow in the small intestine, they ferment carbohydrates that should be absorbed further upstream. This fermentation produces hydrogen and\/or methane gas, causing bloating, distension, pain, and altered motility. Hydrogen-producing bacteria tend to cause diarrhea (IBS-D). Methane-producing archaea slow transit and cause constipation (IBS-C).<\/p>\n<p>The mechanism behind post-infectious IBS, which accounts for roughly 10% of all IBS cases, further cements this connection. Food poisoning triggers an autoimmune response against vinculin, a protein essential for the migrating motor complex (MMC). When the MMC is damaged, the sweeping waves that clear bacteria from the small intestine between meals are impaired. Bacteria accumulate. SIBO develops. IBS symptoms follow.<\/p>\n<p>This is why the anti-vinculin and anti-CdtB antibody test (marketed as ibs-smart) can be so valuable, it can identify the autoimmune mechanism driving both the SIBO and the IBS, confirming that treating the SIBO is the right approach.<\/p>\n<p>For a deep dive into SIBO testing and treatment protocols, see our complete <a href=\"\/blog\/sibo\/\">SIBO guide<\/a>.<\/p>\n<div style=\"background-color:#fff8e1;border-left:4px solid #ffcc02;border-radius:8px;padding:20px 24px;margin:28px 0;\">\n<p style=\"margin:0;font-size:1.05em;\"><strong>The clinical implication:<\/strong> If you have IBS and haven&#8217;t been tested for SIBO, you may be managing symptoms of a condition that could be directly treated. A simple lactulose or glucose breath test can change the entire trajectory of your care.<\/p>\n<\/div>\n<h2>Testing Beyond the &#8220;Diagnosis of Exclusion&#8221;<\/h2>\n<p>The conventional approach to IBS diagnosis is exclusionary: rule out celiac disease, inflammatory bowel disease, colorectal cancer, and thyroid disorders. If nothing shows up, you get the IBS label. This approach misses a tremendous amount.<\/p>\n<p>A thorough IBS workup should include:<\/p>\n<p><strong>SIBO Breath Testing:<\/strong> The lactulose breath test measures hydrogen and methane gas production over 2-3 hours after consuming a lactulose solution. A glucose breath test is an alternative with higher specificity but lower sensitivity. These tests can identify hydrogen-dominant SIBO, methane-dominant overgrowth (IMO), or hydrogen sulfide-dominant SIBO (with newer trio-smart testing). This single test reshapes the treatment plan for the majority of IBS patients.<\/p>\n<p><strong>GI-MAP (in-depth Stool Analysis):<\/strong> This DNA-based stool test quantifies beneficial and pathogenic bacteria, parasites, yeast, viral markers, and digestive function markers including pancreatic elastase, steatocrit (fat malabsorption), calprotectin (inflammation), and secretory IgA (immune function). It can reveal infections, dysbiosis patterns, and digestive insufficiencies that standard testing misses entirely.<\/p>\n<p><strong>Food Sensitivity Testing:<\/strong> While IgG food sensitivity panels remain controversial in conventional medicine, many integrative practitioners find IgG\/IgA combination panels clinically useful, especially when paired with elimination diet protocols. At minimum, testing for celiac disease (tTG-IgA and total IgA) and lactose intolerance should be standard. Fructose malabsorption breath testing is also valuable.<\/p>\n<p><strong>Lactulose Challenge (Intestinal Permeability):<\/strong> The lactulose-mannitol test can assess intestinal permeability, what&#8217;s colloquially called <a href=\"\/blog\/leaky-gut\/\">leaky gut<\/a>. Increased intestinal permeability is found in a significant subset of IBS patients, particularly IBS-D, and correlates with symptom severity.<\/p>\n<p><strong>Anti-Vinculin\/Anti-CdtB Antibodies (ibs-smart):<\/strong> As mentioned above, this blood test identifies the autoimmune mechanism behind post-infectious IBS and SIBO. A positive result confirms the diagnosis and helps predict relapse risk.<\/p>\n<p><strong>Motility Testing:<\/strong> For patients with suspected motility disorders, wireless motility capsule (SmartPill) or antroduodenal manometry can assess gastric emptying and small bowel transit. Impaired motility is both a cause and consequence of SIBO.<\/p>\n<h2>IBS Treatment: An Evidence-Based Hierarchy<\/h2>\n<p>Not all IBS treatments are created equal. Below, we&#8217;ve organized interventions by the strength of evidence supporting them, so you can prioritize what&#8217;s most likely to help.<\/p>\n<h3>Dietary Interventions<\/h3>\n<p><strong>Low-FODMAP Diet<\/strong>, <span style=\"background-color:#c8e6c9;padding:3px 10px;border-radius:6px;font-weight:bold;font-size:0.95em;\">ESTABLISHED<\/span><\/p>\n<p>The low-FODMAP diet is the single most studied dietary intervention for IBS, with a response rate of approximately 50-80% across multiple randomized controlled trials. FODMAPs (Fermentable Oligosaccharides, Disaccharides, Monosaccharides, And Polyols) are short-chain carbohydrates that are poorly absorbed and rapidly fermented by gut bacteria. The diet involves three phases: a strict 2-6 week elimination phase, a systematic reintroduction phase to identify personal triggers, and a long-term modified diet that restricts only your specific triggers. Monash University maintains the gold-standard FODMAP database and app.<\/p>\n<p>Critical point: the low-FODMAP diet is a <em>diagnostic tool<\/em>, not a permanent diet. Long-term strict restriction reduces microbiome diversity, the opposite of what most IBS patients need. Work with a FODMAP-trained dietitian to navigate reintroduction properly.<\/p>\n<h3>Comparison: IBS Diet Approaches<\/h3>\n<table style=\"width:100%;border-collapse:collapse;margin:24px 0;font-size:1em;\">\n<thead>\n<tr style=\"background-color:#e8f5e9;\">\n<th style=\"padding:12px 16px;text-align:left;border-bottom:2px solid #a5d6a7;\">Diet<\/th>\n<th style=\"padding:12px 16px;text-align:left;border-bottom:2px solid #a5d6a7;\">Mechanism<\/th>\n<th style=\"padding:12px 16px;text-align:left;border-bottom:2px solid #a5d6a7;\">Best For<\/th>\n<th style=\"padding:12px 16px;text-align:left;border-bottom:2px solid #a5d6a7;\">Evidence Level<\/th>\n<th style=\"padding:12px 16px;text-align:left;border-bottom:2px solid #a5d6a7;\">Limitations<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #e0e0e0;\">\n<td style=\"padding:12px 16px;font-weight:bold;\">Low FODMAP<\/td>\n<td style=\"padding:12px 16px;\">Reduces fermentable substrates for gut bacteria<\/td>\n<td style=\"padding:12px 16px;\">IBS-D, bloating-predominant IBS, SIBO<\/td>\n<td style=\"padding:12px 16px;\">Strong (multiple RCTs)<\/td>\n<td style=\"padding:12px 16px;\">Restrictive; reduces microbiome diversity if maintained long-term; requires dietitian guidance<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #e0e0e0;background-color:#fafafa;\">\n<td style=\"padding:12px 16px;font-weight:bold;\">SCD (Specific Carbohydrate Diet)<\/td>\n<td style=\"padding:12px 16px;\">Eliminates complex carbohydrates that feed pathogenic bacteria<\/td>\n<td style=\"padding:12px 16px;\">IBD overlap, severe dysbiosis<\/td>\n<td style=\"padding:12px 16px;\">Moderate (smaller studies, strong clinical reports)<\/td>\n<td style=\"padding:12px 16px;\">Very restrictive; difficult to maintain socially; limited RCT data for IBS specifically<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #e0e0e0;\">\n<td style=\"padding:12px 16px;font-weight:bold;\">Elimination Diet<\/td>\n<td style=\"padding:12px 16px;\">Identifies individual food triggers through systematic removal and reintroduction<\/td>\n<td style=\"padding:12px 16px;\">Suspected food sensitivities, IgG-reactive foods<\/td>\n<td style=\"padding:12px 16px;\">Moderate (well-established methodology, variable IBS-specific data)<\/td>\n<td style=\"padding:12px 16px;\">Time-intensive (6-8 weeks minimum); requires careful tracking; risk of unnecessary restriction<\/td>\n<\/tr>\n<tr style=\"background-color:#fafafa;\">\n<td style=\"padding:12px 16px;font-weight:bold;\">Mediterranean Diet<\/td>\n<td style=\"padding:12px 16px;\">Anti-inflammatory; supports microbiome diversity through polyphenols, fiber variety, and omega-3s<\/td>\n<td style=\"padding:12px 16px;\">Long-term gut health maintenance, mild IBS, post-treatment maintenance<\/td>\n<td style=\"padding:12px 16px;\">Strong (for overall health; emerging for IBS specifically)<\/td>\n<td style=\"padding:12px 16px;\">May not provide sufficient symptom relief during active flares; some high-FODMAP foods included<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h3>Pharmaceutical Treatments<\/h3>\n<p><strong>Rifaximin (Xifaxan) for IBS-D<\/strong>, <span style=\"background-color:#c8e6c9;padding:3px 10px;border-radius:6px;font-weight:bold;font-size:0.95em;\">ESTABLISHED<\/span><\/p>\n<p>Rifaximin is FDA-approved for IBS-D based on the TARGET 1 and TARGET 2 trials, which demonstrated significant improvement in global IBS symptoms and bloating. It&#8217;s a non-absorbed antibiotic, meaning it works locally in the gut with minimal systemic side effects. The standard protocol is 550mg three times daily for 14 days. Approximately 44% of patients respond to the first course, and retreatment is effective for relapse. For patients with confirmed SIBO, rifaximin addresses the bacterial overgrowth directly. For methane-dominant cases (IBS-C), rifaximin is typically combined with neomycin or metronidazole.<\/p>\n<p><strong>Antispasmodics<\/strong>, <span style=\"background-color:#c8e6c9;padding:3px 10px;border-radius:6px;font-weight:bold;font-size:0.95em;\">ESTABLISHED<\/span><\/p>\n<p>Antispasmodics like hyoscine (Buscopan), dicyclomine (Bentyl), and otilonium bromide reduce smooth muscle spasm in the intestinal wall. A Cochrane review found them superior to placebo for abdominal pain and global symptom improvement. They work best as rescue medications for acute cramping rather than daily preventive therapy. Peppermint oil (discussed below) works through a similar mechanism with fewer side effects.<\/p>\n<p><strong>Low-Dose Naltrexone (LDN)<\/strong>, <span style=\"background-color:#fff9c4;padding:3px 10px;border-radius:6px;font-weight:bold;font-size:0.95em;\">PROMISING<\/span><\/p>\n<p>At doses of 1.5-4.5mg (far below the standard 50mg dose used for addiction), naltrexone has anti-inflammatory and immunomodulatory effects that can benefit IBS, particularly when there&#8217;s an inflammatory or autoimmune component. Small studies and extensive clinical reports show improvements in pain, bloating, and bowel function. LDN modulates the immune system through transient opioid receptor blockade, upregulating endorphin production and reducing pro-inflammatory cytokines. It&#8217;s especially worth considering when IBS overlaps with other conditions like fibromyalgia or <a href=\"\/blog\/mcas\/\">MCAS<\/a>. Learn more in our <a href=\"\/blog\/low-dose-naltrexone\/\">LDN guide<\/a>.<\/p>\n<p><strong>Peppermint Oil (Enteric-Coated)<\/strong>, <span style=\"background-color:#fff9c4;padding:3px 10px;border-radius:6px;font-weight:bold;font-size:0.95em;\">PROMISING<\/span><\/p>\n<p>Enteric-coated peppermint oil capsules (typically 180-200mg, 2-3 times daily before meals) act as a natural calcium channel blocker, relaxing intestinal smooth muscle. A meta-analysis in BMC Complementary Medicine and Therapies found peppermint oil significantly superior to placebo for global IBS symptoms and abdominal pain. The enteric coating is essential, without it, peppermint oil can cause heartburn by relaxing the lower esophageal sphincter. IBGard is the most studied formulation.<\/p>\n<h3>Mind-Body and Neuroscience-Based Treatments<\/h3>\n<p><strong>Gut-Directed Hypnotherapy<\/strong>, <span style=\"background-color:#c8e6c9;padding:3px 10px;border-radius:6px;font-weight:bold;font-size:0.95em;\">ESTABLISHED<\/span><\/p>\n<p>This is one of the most underutilized treatments in all of IBS care, and the evidence behind it is remarkably strong. Gut-directed hypnotherapy, a specialized form of clinical hypnosis targeting gut function, has been studied in over 15 randomized controlled trials and consistently shows response rates of 70-80%. The Manchester protocol, developed by Peter Whorwell&#8217;s group, involves 7-12 sessions and has demonstrated benefits lasting up to 5 years after treatment. It works by recalibrating the gut-brain axis: reducing visceral hypersensitivity, normalizing gut motility, and decreasing the brain&#8217;s pain processing response to gut signals. The Nerva app (developed by Monash University researchers) provides a digital version of this approach, making it accessible regardless of location.<\/p>\n<p><strong>Vagus Nerve Stimulation and Exercises<\/strong>, <span style=\"background-color:#fff9c4;padding:3px 10px;border-radius:6px;font-weight:bold;font-size:0.95em;\">PROMISING<\/span><\/p>\n<p>The vagus nerve is the primary communication highway between the gut and the brain, and vagal tone is consistently reduced in IBS patients. Practices that stimulate the vagus nerve, including cold water face immersion, gargling, singing, specific breathing techniques (especially extended exhalation), and transcutaneous vagus nerve stimulation (tVNS) devices, can improve gut-brain communication, reduce visceral hypersensitivity, and promote the &#8220;rest and digest&#8221; parasympathetic state. While individual studies are still emerging, the physiological rationale is solid and the interventions are essentially risk-free.<\/p>\n<h3>Targeted Supplementation<\/h3>\n<p><strong>Strain-Specific Probiotics<\/strong>, <span style=\"background-color:#fff9c4;padding:3px 10px;border-radius:6px;font-weight:bold;font-size:0.95em;\">PROMISING<\/span><\/p>\n<p>The keyword here is <em>strain-specific<\/em>. Generic probiotics are unlikely to help IBS and may worsen bloating. But specific strains have meaningful evidence:<\/p>\n<ul>\n<li><strong>Bifidobacterium infantis 35624 (Alflorex\/Align):<\/strong> The most studied probiotic for IBS, shown to reduce pain, bloating, and bowel dysfunction in multiple RCTs<\/li>\n<li><strong>Saccharomyces boulardii:<\/strong> Particularly useful for IBS-D, with anti-inflammatory and antimicrobial properties<\/li>\n<li><strong>Lactobacillus plantarum 299v:<\/strong> Demonstrated benefit for abdominal pain and bloating<\/li>\n<li><strong>VSL#3 \/ Visbiome:<\/strong> High-dose multi-strain formulation with evidence for bloating reduction<\/li>\n<\/ul>\n<p>Important: if you have active SIBO, adding probiotics before addressing the overgrowth can worsen symptoms. Sequence matters.<\/p>\n<div style=\"background-color:#fff3e0;border-left:4px solid #ff9800;border-radius:8px;padding:20px 24px;margin:28px 0;\">\n<p style=\"margin:0;font-size:1.08em;\"><strong>IBS is NOT a life sentence.<\/strong> When you move beyond symptom suppression and investigate root causes, SIBO, post-infectious autoimmunity, microbiome disruption, food triggers, gut-brain axis dysfunction, many patients achieve complete or near-complete resolution of symptoms. The key is refusing to accept &#8220;just IBS&#8221; as a final answer and pursuing the testing and treatment approaches outlined above.<\/p>\n<\/div>\n<h2>Evidence Grading: How We Evaluate IBS Treatments<\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:24px 0;font-size:1em;\">\n<thead>\n<tr style=\"background-color:#e8f5e9;\">\n<th style=\"padding:12px 16px;text-align:left;border-bottom:2px solid #a5d6a7;\">Evidence Grade<\/th>\n<th style=\"padding:12px 16px;text-align:left;border-bottom:2px solid #a5d6a7;\">Definition<\/th>\n<th style=\"padding:12px 16px;text-align:left;border-bottom:2px solid #a5d6a7;\">IBS Examples<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr style=\"border-bottom:1px solid #e0e0e0;\">\n<td style=\"padding:12px 16px;\"><span style=\"background-color:#c8e6c9;padding:3px 10px;border-radius:6px;font-weight:bold;\">ESTABLISHED<\/span><\/td>\n<td style=\"padding:12px 16px;\">Multiple large RCTs, systematic reviews, or FDA approval; consistent effect across populations<\/td>\n<td style=\"padding:12px 16px;\">Low-FODMAP diet, rifaximin for IBS-D, antispasmodics, gut-directed hypnotherapy<\/td>\n<\/tr>\n<tr style=\"border-bottom:1px solid #e0e0e0;background-color:#fafafa;\">\n<td style=\"padding:12px 16px;\"><span style=\"background-color:#fff9c4;padding:3px 10px;border-radius:6px;font-weight:bold;\">PROMISING<\/span><\/td>\n<td style=\"padding:12px 16px;\">Smaller RCTs, strong mechanistic rationale, consistent clinical outcomes; not yet definitive<\/td>\n<td style=\"padding:12px 16px;\">Peppermint oil, strain-specific probiotics, LDN, vagus nerve stimulation<\/td>\n<\/tr>\n<tr>\n<td style=\"padding:12px 16px;\"><span style=\"background-color:#ffccbc;padding:3px 10px;border-radius:6px;font-weight:bold;\">EARLY RESEARCH<\/span><\/td>\n<td style=\"padding:12px 16px;\">Preliminary studies, case series, or strong theoretical basis; insufficient controlled data<\/td>\n<td style=\"padding:12px 16px;\">Fecal microbiota transplant for IBS, serum-derived bovine immunoglobulin (SBI)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>Frequently Asked Questions About IBS<\/h2>\n<h3>Is IBS a real medical condition or is it psychosomatic?<\/h3>\n<p>IBS is absolutely a real medical condition with measurable physiological abnormalities, including altered gut motility, visceral hypersensitivity, immune activation, microbiome changes, and increased intestinal permeability. The outdated notion that IBS is &#8220;all in your head&#8221; has been thoroughly debunked. That said, the gut-brain axis is real, and psychological stress genuinely worsens gut symptoms through measurable pathways (vagal tone changes, mast cell activation, altered motility). This doesn&#8217;t make IBS psychosomatic, it makes it a condition where mind and body are deeply interconnected, which is true of virtually every chronic condition.<\/p>\n<h3>Can IBS be cured or only managed?<\/h3>\n<p>This depends entirely on the underlying cause. Post-infectious IBS driven by SIBO can often be resolved with appropriate antimicrobial treatment and prokinetic therapy. IBS driven by food sensitivities can be managed through identification and avoidance. IBS driven by visceral hypersensitivity can be significantly improved through gut-directed hypnotherapy. The &#8220;IBS is lifelong&#8221; narrative reflects a model that treats the label instead of investigating the mechanism. When root causes are identified and addressed, many patients achieve sustained remission.<\/p>\n<h3>Should I get tested for SIBO if I have IBS?<\/h3>\n<p>Yes, this should be considered standard of care, given that up to 78% of IBS patients test positive for SIBO. A lactulose breath test (or the newer trio-smart test that also measures hydrogen sulfide) is non-invasive, relatively inexpensive, and can completely change your treatment approach. If your gastroenterologist dismisses SIBO testing, consider consulting an integrative or functional medicine practitioner.<\/p>\n<h3>What&#8217;s the difference between IBS and IBD?<\/h3>\n<p>IBD (inflammatory bowel disease), which includes Crohn&#8217;s disease and ulcerative colitis, involves visible, measurable structural inflammation and damage to the intestinal lining. It&#8217;s diagnosed through endoscopy and biopsy. IBS, by contrast, is classified as a functional disorder without visible structural damage on standard endoscopy. However, research has identified low-grade mucosal inflammation, mast cell activation, and increased intestinal permeability in many IBS patients, blurring the line between &#8220;functional&#8221; and &#8220;organic.&#8221; Some patients have both IBS and IBD simultaneously.<\/p>\n<h3>Does stress cause IBS?<\/h3>\n<p>Stress doesn&#8217;t cause IBS in the way a bacteria causes an infection, but it&#8217;s a significant perpetuating and exacerbating factor. Chronic stress reduces vagal tone, increases gut permeability, alters the microbiome, activates intestinal mast cells, and impairs the migrating motor complex. Many IBS patients can trace their onset to a period of high stress, often combined with another trigger (food poisoning, antibiotic use, or surgery). Managing stress through evidence-based approaches, particularly gut-directed hypnotherapy, which addresses both stress response and gut function simultaneously, is a legitimate and important part of IBS treatment.<\/p>\n<h3>Are there specific foods everyone with IBS should avoid?<\/h3>\n<p>No, and this is a critical point. IBS triggers are highly individual. While FODMAPs are the most common category of triggers, not everyone with IBS reacts to the same FODMAPs, and some IBS patients tolerate FODMAPs fine but react to other compounds (histamine, oxalates, salicylates, lectins). The purpose of the low-FODMAP elimination phase is to identify <em>your<\/em> specific triggers through systematic reintroduction. Blanket food avoidance without a structured process leads to unnecessarily restrictive diets that harm quality of life and microbiome diversity.<\/p>\n<h3>What role does the microbiome play in IBS, and should I take probiotics?<\/h3>\n<p>The microbiome is central to IBS pathophysiology. Reduced diversity, altered composition, and SIBO are consistently found in IBS patients. However, &#8220;take a probiotic&#8221; is overly simplistic advice. Generic probiotics may worsen bloating, especially in patients with SIBO. Strain-specific probiotics (like Bifidobacterium infantis 35624 or Saccharomyces boulardii) have the best evidence. The microbiome is better supported through dietary diversity, prebiotic fiber (after SIBO is addressed), and avoiding unnecessary antibiotics, rather than through probiotics alone.<\/p>\n<h3>Can IBS cause symptoms beyond the gut, like brain fog and fatigue?<\/h3>\n<p>Absolutely. IBS frequently coexists with extra-intestinal symptoms including <a href=\"\/blog\/brain-fog\/\">brain fog<\/a>, fatigue, joint pain, headaches, and sleep disturbance. These systemic symptoms are likely driven by increased intestinal permeability (allowing bacterial endotoxins into the bloodstream), neuroinflammation via the gut-brain axis, nutrient malabsorption (particularly in SIBO), and immune activation. Addressing the gut component often improves these seemingly unrelated symptoms, which makes sense when you understand the gut as a central regulator of systemic inflammation and immune function.<\/p>\n<h2>Related Topics<\/h2>\n<div style=\"background-color:#f5f5f5;border-radius:12px;padding:24px 28px;margin:28px 0;\">\n<p style=\"font-size:1.08em;margin-top:0;\">Explore conditions and treatments closely connected to IBS:<\/p>\n<ul style=\"font-size:1.05em;line-height:2;margin-bottom:0;\">\n<li><a href=\"\/blog\/sibo\/\">SIBO (Small Intestinal Bacterial Overgrowth)<\/a>, the most common root cause hiding behind the IBS label<\/li>\n<li><a href=\"\/blog\/leaky-gut\/\">Leaky Gut (Intestinal Permeability)<\/a>, the barrier dysfunction linking gut symptoms to systemic inflammation<\/li>\n<li><a href=\"\/blog\/brain-fog\/\">Brain Fog<\/a>, the cognitive symptom that frequently accompanies IBS through the gut-brain axis<\/li>\n<li><a href=\"\/blog\/low-dose-naltrexone\/\">Low-Dose Naltrexone (LDN)<\/a>, a promising immunomodulator for IBS with inflammatory or autoimmune features<\/li>\n<li><a href=\"\/blog\/mcas\/\">Mast Cell Activation Syndrome (MCAS)<\/a>, an often-overlooked driver of IBS symptoms, especially histamine-mediated reactions to food<\/li>\n<\/ul>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>IBS, At a Glance What it is: A functional gastrointestinal disorder defined by the Rome IV criteria, recurrent abdominal pain associated with changes in bowel habits, without structural damage Subtypes: IBS-D (diarrhea-predominant), IBS-C (constipation-predominant), IBS-M (mixed), IBS-U (unsubtyped) Prevalence: Affects 10-15% of the global population; up to 45 million Americans Key insight: Up to 78%&#8230;<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_kad_post_transparent":"","_kad_post_title":"","_kad_post_layout":"","_kad_post_sidebar_id":"","_kad_post_content_style":"","_kad_post_vertical_padding":"","_kad_post_feature":"","_kad_post_feature_position":"","_kad_post_header":false,"_kad_post_footer":false,"_kad_post_classname":"","_regenerated_references":"","footnotes":""},"categories":[991,1008],"tags":[],"class_list":["post-5046","post","type-post","status-publish","format-standard","hentry","category-conditions","category-gut-health-digestive"],"_links":{"self":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5046","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/comments?post=5046"}],"version-history":[{"count":2,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5046\/revisions"}],"predecessor-version":[{"id":5289,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/posts\/5046\/revisions\/5289"}],"wp:attachment":[{"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/media?parent=5046"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/categories?post=5046"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regenerated.com\/blog\/wp-json\/wp\/v2\/tags?post=5046"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}